The compound also significantly reduced the levels of AP-1 dependent proliferation markers including PCNA, IGF-1, c-fos and c-jun in both MDA-MB 231 cells and primary breast adenocarcinoma cells (Fig. 4C). Here, JUN is linked to breast adenocarcinoma.